Innoviva Stock (NASDAQ:INVA), Quotes and News Summary

Q: What sector and industry does Innoviva (INVA) operate in?

Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Innoviva Stock (NASDAQ: INVA) stock price, news, charts, stock research, profile.

Open	$15.360
Close	$15.600
Volume / Avg.	759.101K / 704.034K
Day Range	15.345 - 15.800
52 Wk Range	11.550 - 16.865
Market Cap	$974.139M
P/E Ratio	6.824
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	36.46%
Days to Cover	19.17

Recent News

AstraZeneca-Spin Off Entasis Secures FDA Approval For First Pathogen-Targeted Therapy Addressing Acinetobacter

Vandana Singh

Over $125M Bet On Occidental Petroleum? Check Out These 4 Stocks Insiders Are Buying

Although US stocks closed higher on Monday, there were a few notable insider trades.

Lisa Levin

Elon Musk Says US Intel Agencies Had Access To Twitter DMs, Alibaba's Ant IPO Might Actually See Light, Airbus Pushes Some 2024 Deliveries: Today's Top Stories

Benzinga Elon Musk Drops Bombshell: US Intel Agencies Were Reading Your Twitter DMs

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Innoviva (INVA) stock?

You can purchase shares of Innoviva (NASDAQ: INVA) through any online brokerage.

View our list of the best stock brokerages.

Who are Innoviva's (INVA) competitors?

Other companies in Innoviva’s space includes: GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN) and WAVE Life Sciences (NASDAQ:WVE).

What is the target price for Innoviva (INVA) stock?

The latest price target for Innoviva (NASDAQ: INVA) was reported by EF Hutton on Wednesday, May 10, 2023. The analyst firm set a price target for 22.50 expecting INVA to rise to within 12 months (a possible 44.23% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Innoviva (INVA)?

The stock price for Innoviva (NASDAQ: INVA) is $15.6 last updated May 10, 2024 at 4:01 PM EDT.

Does Innoviva (INVA) pay a dividend?

There are no upcoming dividends for Innoviva.

When is Innoviva (NASDAQ:INVA) reporting earnings?

Innoviva’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Is Innoviva (INVA) going to split?

There is no upcoming split for Innoviva.

What sector and industry does Innoviva (INVA) operate in?

Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-